Form D · Biotechnology

Xcede Technologies, Inc.

Rochester, MN · CIK 0001589501

Offering snapshot reported Nov 30, 2015 · SEC filing

Reported sold
$2.97M
Offering amount: $3M
Investors reported
26
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Oct 2, 2013
As reported in this filing

Fundraising history

Reported sold
Reported amount sold by Form D filing date$0$1.48M$2.97MOct 17, 2013: $565,555.00Oct 17, 2013Nov 30, 2015: $2,965,918.00Nov 30, 2015

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

  • Reported sold$565,555 → $2,965,918
  • Reported investors6 → 26

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Nov 30, 2015Amendment$2,965,918$2,400,363vs Oct 17, 201326SEC filing
Oct 17, 2013Initial$565,555No comparison6SEC filing

Offering details

Securities
Debt, Option to acquire, Security to be acquired
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-204754

Source: Form D, filed Nov 30, 2015. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Allen Berning Director, Executive
Sarah Combs Director, Executive
Michael Joyner Director
Patricia M. Kehe Executive
Thomas Leonard Director, Executive
Vic Schmitt Director, Executive
Peter Sulick Director, Executive
Linda Zuckerman Executive

Issuer details

Industry: Biotechnology (See others in industry)

Address:
1815 14 Th Street Nw
Rochester, MN, 55901